Ixj: Pure Pharma Against—A Global Healthcare Bet Today
Two popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...
Two popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...
Bitwise’s new HYPE ETF posts strong initial demand on its NYSE debut, drawing multi-million flows and signaling risin...
U.S. stocks push higher on May 27, 2026, as oil slips below $90 a barrel, lifting risk appetite. The S&P 500 and SPY ...
Webull defied flat profits with rapid top‑line growth in Q1 2026, but costs rose sharply and regulatory headwinds loo...
As mega-cap tech valuations wobble, a rare under-$30 stock with solid cash flow and a growing media footprint stands ...
The trillion-dollar club has swelled to 14 as of late May 2026, led by AI-enabled tech giants. The combined market ca...
Tech stocks lead gains as the Nasdaq Composite climbs to fresh highs, fueled by AI optimism and strong earnings momen...
Market chatter surrounding SpaceX’s potential June 12 IPO reignites talk that Elon Musk could become the world’s firs...
Stocks extend an eight-week gain streak, signaling persistent momentum amid easing volatility. Here’s what traders ar...
A top AI stock is flirting with a $1.6 trillion market value as optimism for AI-driven growth runs hot. Yet traders a...
Retirees are weighing 401(K) rollovers to traditional IRAs as SECURE 2.0 tweaks and market volatility shift retiremen...
A JPMorgan forecast suggests the S&P 500 could rise about 22% from current levels to roughly 9,000 by mid-2027, led b...